Gamida Cell Competitors, Revenue and Alternatives
Navigation
Overview
Estimated Revenue & Financials
- Gamida Cell's estimated annual revenue is currently $11.2M per year.
- Gamida Cell's estimated revenue per employee is $155,000
- Gamida Cell's total funding is $203.1M.
Employee Data
- Gamida Cell has 72 Employees.
- Gamida Cell grew their employee count by 1% last year.
- Gamida Cell currently has 3 job openings.
Gamida Cell Competitors
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
| $11.2M | 72 | 1% | N/A |
What Is Gamida Cell?
Gamida Cell is a leader in cellular and immune therapeutics, committed to changing the treatment paradigm for patients with cancer and rare genetic diseases. We are building a broad pipeline based on our proprietary NAM technology platform. Our lead program, NiCord, is in phase 3 development for allogeneic bone marrow transplantation and was granted Breakthrough Therapy Designation by the FDA.
keywords:N/A72
Number of Employees
$11.2M
Revenue (est)
3
Current Jobs
1%
Employee Growth %
$203.1M
Total Funding
N/A
Valuation
N/A
Accelerator
N/A
Type
Executive Contacts
| Name | Title | |
|---|---|---|
| Lindsay Luke | VP, Professional Alliances | |
| Jaren Madden | Vice President, Investor Relations and Corporate Communications | Email Available |
| Paul Nee | Vice President Marketing | Email Available |
| Josh Hamermesh | Chief Business Officer | Email Available |
| John Uhrin | Sr Director , Customer Experience & Patient Services | |
| Ronit Simantov | Chief Medical Officer | Email Available |
| Chad Boily | Study Logistics Manager | |
| Debbie Chirnomas | VP, Clinical Development and Medical Affairs | |
| Zelda Wildman | Medical Manager | |
| Tracey Lodie | Chief Scientific Officer |
Gamida Cell News
Gamida Cell Ltd. GMDA has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Every investor in Gamida Cell Ltd. (NASDAQ:GMDA) should be aware of the most powerful shareholder groups. Insiders often own a large ...
Gamida Cell Ltd. (NASDAQ:GMDA) Q2 2019 Earnings Conference Call August 6, 2019 8:30 AM ET. Company Participants. Julian Adams - ...